Evid Invest
Who owns ZBIOWhat ZBIO owns — n/a

Who owns Zenas BioPharma, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of ZBIO from SEC Form 13F filings across 153 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 153 institutions disclosed 68.1M shares of Zenas BioPharma, Inc. worth $1.84B — about 103% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

153

13F holders

$1.84B

value, 2026 filers

103%

of shares outstanding (68.1M sh)

24

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ZBIO's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC9.8M$264.1M0.0%14.8%+3.0%
2WELLINGTON MANAGEMENT GROUP LLP8.1M$218.3M0.0%12.2%+407.9%
3SR ONE CAPITAL MANAGEMENT, LP5.0M$135.9M11.8%7.6%0.0%
4NEA Management Company, LLC4.0M$108.5M8.0%6.1%0.0%
5BlackRock, Inc.3.3M$89.9M0.0%5%+24.1%
6FEDERATED HERMES, INC.3.1M$83.8M0.1%4.7%-0.3%
7Capital International Investors2.9M$78.9M0.0%4.4%+16.9%
8ENAVATE SCIENCES GP, LLC2.9M$78.7M28.1%4.4%-25.5%
9Polar Capital Holdings Plc2.4M$64.9M0.2%3.6%-0.3%
10Royalty Pharma Sub-Manager, LLC2.4M$64.4M32.8%3.6%0.0%
11Fairmount Funds Management LLC2.4M$64.0M4.0%3.6%+0.5%
12STATE STREET CORP1.9M$50.8M0.0%2.8%-8.4%
13NVP ASSOCIATES, LLC1.8M$49.6M17.6%2.8%0.0%
14VANGUARD CAPITAL MANAGEMENT LLC1.7M$46.5M0.0%2.6%+27.1%
15PRICE T ROWE ASSOCIATES INC /MD/1.1M$29.3M0.0%1.6%-11.3%
16ALLIANCEBERNSTEIN L.P.1.1M$28.6M0.0%1.6%-3.9%
17GEODE CAPITAL MANAGEMENT, LLC1.1M$28.6M0.0%1.6%+20.1%
18TWO SIGMA INVESTMENTS, LP833,288$22.5M0.0%1.3%+2.2%
19EcoR1 Capital, LLC789,500$21.3M0.9%1.2%0.0%
20GOLDMAN SACHS GROUP INC774,621$20.9M0.0%1.2%+185.7%
21BANK OF AMERICA CORP /DE/683,308$18.4M0.0%1%-44.5%
22Candriam S.C.A.NEW654,833$17.7M0.1%1%new
23Woodline Partners LP590,969$15.9M0.0%0.9%+0.1%
24ArrowMark Colorado Holdings LLC527,976$14.2M0.7%0.8%-7.9%
25Rock Springs Capital Management LP502,077$13.5M0.7%0.8%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.